Fortress Biotech, Inc. Avenue Therapeutics, Inc. (ATXI) insider trading activity

Fortress Biotech, Inc. is of AVENUE THERAPEUTICS, INC.. Currently has a direct ownership of 328,524 shares of ATXI, which is worth approximately $101,842. The most recent transaction as insider was on Mar 31, 2025, when has been sold 33,724 shares (Common Stock, par value $0.0001) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 329K

90.74% 3M change

89.52% 12M change

Total Value Held $101,842

Fortress Biotech, Inc. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 31 2025	BUY Grant, award, or other acquisition	-	33,724 Added 9.31%	328,524 Common Stock, par valu...
Apr 16 2024	BUY Grant, award, or other acquisition	-	413,507 Added 10.44%	3,547,393 Common Stock, par valu...
Jan 02 2024	BUY Grant, award, or other acquisition	-	2,101,496 Added 40.14%	3,133,886 Common Stock, par valu...
Sep 08 2023	BUY Open market or private purchase	$301,255 $0.72 p/Share	418,410 Added 28.84%	1,032,390 Common Stock
Mar 31 2023	BUY Grant, award, or other acquisition	-	52,419 Added 7.87%	613,980 Common Stock, par valu...
Jan 03 2023	BUY Grant, award, or other acquisition	-	231,316 Added 29.17%	561,561 Common Stock, par valu...
Dec 31 2022	BUY Grant, award, or other acquisition	-	90,909 Added 21.59%	330,245 Common Stock, par valu...

Also insider at

CKPT

Checkpoint Therapeutics, Inc. Healthcare

MBIO

MUSTANG BIO, INC. Healthcare

DERM

Journey Medical Corp Healthcare

> 10% Shareholder

FBI